Get notified when HIMS files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Fda Named Company In Statement; Hhs Referred To Doj (new) — First disclosure of federal enforcement scrutiny targeting compounded GLP-1 marketing and potential drug-law violations.
  • Litigation Risk Factor Broadened From 'Ordinary Course' To 'Legal And Regulatory Proceedings And Inquiries' (worsened) — Reflects non-ordinary regulatory matters including the DOJ referral.
NYSE: HIMS Hims & Hers Health, Inc. 10-Q

HIMS revenue +38% to $753M in Q2 but swings to $97M operating loss on GLP-1 pivot

Filed August 10, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 4, 2025 · ~1 min read

Key Changes

  • high

    Operating income swung from $26.7M profit to $97.2M loss YoY while revenue grew 38%, driven by strategic shift to branded GLP-1s with lower margins and higher procurement costs.

    MD&A: Operating Results verify on EDGAR →
  • high

    FDA named the company in Feb 2026 statement targeting compounded GLP-1 marketing; HHS referred HIMS to DOJ for potential violations of drug laws. Outcome unclear but could bring penalties, operational disruptions, or reputational harm.

    Risk Factors: FDA/DOJ Investigation verify on EDGAR →
  • high

    March 2026 strategic shift prioritizes branded GLP-1 medications over compounded alternatives and introduces membership program. Risks include customer unwillingness to pay higher prices, margin compression, and supply-chain dependencies on third-party manufacturers.

    Risk Factors: Strategic Shift verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (GREE 10-Q) is open in full — no account needed.

Partner

Trade HIMS commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov View full financials on EDGAR ↗

Figures/quotes linked to EDGAR · Narrative written by AI · Aug 19, 2026 · How we verify